Asset
LUNACALCIPOL
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00742716 | phase2 | completed | 2008-10-01 | 2010-02-01 | OPKO IP Holdings II, Inc. | Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease |
| NCT00384098 | phase2 | completed | 2006-09-01 | 2007-05-01 | OPKO Health, Inc. | Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis |
FDA applications (0)
This company has no applications containing this asset.